Stocks and Investing Stocks and Investing
Wed, September 22, 2021
[ 12:00 AM ] - WOPRAI
Keith Bachman Maintained (ADBE) at Buy with Decreased Target to $720 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Brent Thill Maintained (ADBE) at Strong Buy with Increased Target to $760 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Brad Sills Maintained (ADBE) at Strong Buy with Increased Target to $720 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
David Kelley Maintained (APH) at Strong Buy with Increased Target to $44 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Ivan Feinseth Maintained (AAPL) at Strong Buy with Increased Target to $198 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Lisa Ellis Upgraded (ACN) to Strong Buy and Held Target at $405 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Samuel Bland Initiated (ZIM) at Sell and Held Target at $46 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Frederic Bastien Upgraded (BEP) to Buy and Increased Target to $44 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Stephen Manaker Initiated (AHH) at Strong Buy and Held Target at $15 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Difei Yang Maintained (BLUE) at Strong Buy with Decreased Target to $23 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Anthony Crowdell Maintained (BKH) at Hold with Increased Target to $67 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Pamela Kaufman Maintained (BRBR) at Buy with Increased Target to $37 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
John Vinh Upgraded (AMBA) to Buy and Held Target at $185 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Jon Tower Maintained (CBRL) at Sell with Increased Target to $139 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Brian Mullan Maintained (CBRL) at Strong Buy with Decreased Target to $155 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Jake Bartlett Maintained (CBRL) at Hold with Decreased Target to $152 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Daniel Imbro Maintained (AZO) at Buy on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Brian Nagel Maintained (AZO) at Buy on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Lavesh Hemnani Maintained (AZO) at Buy on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Bobby Griffin Maintained (AZO) at Buy on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Steven Zaccone Maintained (AZO) at Strong Buy on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Simeon Gutman Maintained (AZO) at Hold on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Jay McCanless Maintained (AZO) at Buy on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Joseph Altobello Upgraded (XPOF) to Strong Buy and Held Target at $14 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Matthew Boss Maintained (VFC) at Buy with Decreased Target to $90 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Michael Rose Maintained (VBTX) at Strong Buy with Increased Target to $44 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Timna Tanners Downgraded (VALE) to Hold and Decreased Target to $20 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Steve Barger Maintained (URI) at Buy with Increased Target to $405 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Susan Roth Katzke Maintained (USB) at Hold with Increased Target to $61 on, Sep 22nd, 2021
[ 12:00 AM ] - WOPRAI
Paul Choi Downgraded (VIR) to Hold and Decreased Target to $62 on, Sep 22nd, 2021

Paul Choi Downgraded (VIR) to Hold and Decreased Target to $62 on, Sep 22nd, 2021


Published on 2024-10-27 17:57:45 - WOPRAI, Paul Choi
  Print publication without navigation


Paul Choi of Goldman Sachs, Downgraded "Vir Biotechnology, Inc." (VIR) to Hold and Decreased Target from $64 to $62 on, Sep 22nd, 2021.

Paul has made no other calls on VIR in the last 4 months.



There is 1 other peer that has a rating on VIR. Out of the 1 peers that are also analyzing VIR, 0 agree with Paul's Rating of Hold.



This is the rating of the analyst that currently disagrees with Paul

  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $71 on, Friday, August 6th, 2021
Contributing Sources